Notice Regarding Revisions to Consolidated Earnings Forecast for the Second Quarter (Interim) and Full Year for the Fiscal Year Ending March 2027

Overview of earnings forecast revisions

This material reports an upward revision of the second-quarter (interim) consolidated earnings forecast for the period from April 1, 2026 to September 30, 2026. Revised figures are: net sales 75,000 hundred million yen, operating income 3,100 hundred million yen, ordinary income 3,800 hundred million yen, and net income attributable to owners of the parent of 700 hundred million yen (EPS 18.29 yen). Compared to the same period a year earlier, a substantial improvement is anticipated, with solid performance in the inorganic and organic chemistry divisions.

Full-year outlook and notes

The full-year consolidated earnings forecast remains unchanged at net sales of 150,000 hundred million yen, operating income of 14,200 hundred million yen, and ordinary income of 13,300 hundred million yen, as previously announced. Net income for the year attributable to owners of the parent has not yet been disclosed and may be updated later due to factors such as extraordinary losses. While there is a possibility of additional extraordinary losses related to structural reforms in inorganic chemistry, no specific amounts are known at this time.